Shruti Jolly, MD, MBA

 Shruti Jolly
Associate Chair, Radiation Oncology
Executive Director, Community Practices
Associate Medical Director, Strategic Planning and Business Development
Clinical Professor of Radiation Oncology, Medical School
[email protected]
Available to mentor
Shruti Jolly, MD, MBA
Shruti Jolly
Clinical Professor
  • Qualifications
  • Center Memberships
  • Recent Publications

  • Manage Your Profile

    • Qualifications
    • MBA
      University of Michigan, Ann Arbor, Michigan, United States
      2022 - 2024

    Center Memberships
    • Center Member
      Global REACH
    • Center Member
      Institute for Healthcare Policy and Innovation
    • Center Member
      Rogel Cancer Center

    Recent Publications

     See All Publications
    • Presentation
      Radiation Therapy Advances & QA in NSCLC
      Jolly S. 2026 Feb 11;
    • Presentation
      Building Precision Oncology Capacity: Lessons from Michigan Medicine
      Jolly S. 2026 Feb 11;
    • Presentation
      Enhancing Lung Carica Care Through Data Driven Collaboration
      Jolly S. 2026 Feb 11;
    • Journal Article
      Multi-institutional evaluation of direction-modulated brachytherapy tandems for cervical cancer
      Richeson D, Gholami S, Manandhar B, Alam S, Gautam S, Sohn JJ, Scanderbeg D, Yashar C, Prisciandaro J, Jolly S, Fields E, Beriwal S, Song WY. Academia Oncology, 2025 Oct 31; 2 (3): DOI:10.20935/acadonco7919
    • Journal Article
      Adaptive vs. Non-Adaptive Radiation Dose Escalation in Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC): Indirect Comparison of NRG-RTOG 0617 and 1106 Individual Patient Data
      Miccio JA, Hu C, Kong FM, Samson P, Gelblum D, Loo BW, Videtic GM, Faria S, Jolly S, Tian S, Gerber DE, Welsh JW, Nakhoul I, Gore EM, Lyness J, Bradley JD, Machtay M. International Journal of Radiation Oncology • Biology • Physics, 2025 Sep 28; 123 (1): s197 DOI:10.1016/j.ijrobp.2025.07.1286
    • Proceeding / Abstract / Poster
      Adoption and Practice Patterns of TG263 Standardized Nomenclature in a Statewide Quality Consortium
      Moncion A, Yin M, Grubb M, Piersma N, Matuszak M, Mietzel M, Jolly S, Paximadis P, Marsh R, Hayman J, Abu-Isa E, Critchfield L, Dess R, Heimburger D, Litzenberg D, Vicini F, Pierce L, Covington E. 2025 Sep 27;
    • Journal Article
      Identification of Dosimetric and Clinical Predictors for Post-Treatment Pulmonary Hospitalizations in NSCLC
      Nieto JD, Wang W, Schipper M, Bergsma DP, Hayman JA, Yin H, Dominello MM, Zaki M, Dragovic AF, Kestin LL, Paximadis PA, Matuszak MM, Miller SR, Jolly S. International Journal of Radiation Oncology • Biology • Physics, 2025 Sep 28; 123 (1): e198 DOI:10.1016/j.ijrobp.2025.06.3727
    • Journal Article
      Optimizing Fractionation Strategies for Early-Stage NSCLC: Real-World Toxicity and Outcomes from a Statewide Consortium
      Higgins L, Miller SR, Yin H, Schipper M, Matuszak MM, Zaki M, Hayman JA, Dragovic AF, Dominello MM, Bergsma DP, Paximadis PA, Kestin LL, Jolly S. International Journal of Radiation Oncology • Biology • Physics, 2025 Sep 28; 123 (1): e165 DOI:10.1016/j.ijrobp.2025.06.3656